Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study

TasdemIr, Mehmet; CANPOLAT, Nur; YILDIZ, NURDAN; OzcelIk, Gul; Benzer, Meryem; SAYGILI, Seha; Ozkayin, Emine; Turkkan, Özde; Balat, Ayse; CANDAN, CENGİZ; Celakil, Mehtap; Yavuz, Sevgi; Akinci, Nurver; Goknar, Nilüfer; Akgun, Cihangir; Tulpar, Sebahat; ALPAY, HARİKA; SEVER, Fatma; BIlge, İlmay

doi:10.3906/sag-2012-297

Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study

TasdemIr M., CANPOLAT N., YILDIZ N., OzcelIk G., Benzer M., SAYGILI S. K., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.4, pp.1781-1790, 2021 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 51 Issue: 4
Publication Date: 2021
Doi Number: 10.3906/sag-2012-297
Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Page Numbers: pp.1781-1790
Keywords: Frequently relapsing nephrotic syndrome, immunosuppressive agents, steroid-dependent nephrotic syndrome, steroid-resistant nephrotic syndrome, remission, CHILDHOOD-ONSET, FOLLOW-UP, CYCLOSPORINE
Istanbul University Affiliated: Yes

Abstract

Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen.